Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-051063
Filing Date
2020-04-24
Accepted
2020-04-24 17:04:17
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm201947-5_defa14a.htm DEFA14A 23562
2 GRAPHIC tm201947-5_defa14aimg001.jpg GRAPHIC 72176
3 GRAPHIC tm201947-5_defa14aimg002.jpg GRAPHIC 119369
4 GRAPHIC tm201947-5_defa14aimg003.jpg GRAPHIC 32807
5 GRAPHIC tm201947-5_defa14aimg004.jpg GRAPHIC 5442
  Complete submission text file 0001104659-20-051063.txt   339962
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 20815919
SIC: 2834 Pharmaceutical Preparations